Boiron SA (0DTF.L)

EUR 27.0

(-0.37%)

Total Liabilities Summary of Boiron SA

  • Boiron SA's latest annual total liabilities in 2023 was 198.7 Million EUR , down -14.41% from previous year.
  • Boiron SA's latest quarterly total liabilities in 2024 Q2 was 184.68 Million EUR , down 0.0% from previous quarter.
  • Boiron SA reported annual total liabilities of 232.14 Million EUR in 2022, down -2.84% from previous year.
  • Boiron SA reported annual total liabilities of 238.92 Million EUR in 2021, down -12.37% from previous year.
  • Boiron SA reported quarterly total liabilities of 202.74 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Boiron SA reported quarterly total liabilities of 198.7 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Boiron SA (2023 - 2001)

Historical Annual Total Liabilities of Boiron SA (2023 - 2001)

Year Total Liabilities Total Liabilities Growth
2023 198.7 Million EUR -14.41%
2022 232.14 Million EUR -2.84%
2021 238.92 Million EUR -12.37%
2020 272.65 Million EUR 5.34%
2019 258.82 Million EUR -7.9%
2018 281.03 Million EUR -0.66%
2017 282.91 Million EUR -0.88%
2016 285.43 Million EUR 2.16%
2015 279.4 Million EUR -3.54%
2014 289.67 Million EUR 5.06%
2013 275.72 Million EUR 22.48%
2012 225.12 Million EUR 2.82%
2011 218.95 Million EUR 2.08%
2010 214.49 Million EUR 2.8%
2009 208.65 Million EUR 8.76%
2008 191.85 Million EUR 7.51%
2007 178.44 Million EUR -1.94%
2006 181.97 Million EUR -7.8%
2005 197.37 Million EUR 55.5%
2004 126.92 Million EUR 28.94%
2003 98.44 Million EUR 2.27%
2002 96.26 Million EUR 11.04%
2001 86.69 Million EUR 0.0%

Peer Total Liabilities Comparison of Boiron SA

Name Total Liabilities Total Liabilities Difference
Laboratorios Farmaceuticos Rovi, S.A. 256.39 Million EUR 22.5%
Vetoquinol SA 165.12 Million EUR -20.336%
Valneva SE 341.14 Million EUR 41.755%
AB Science S.A. 46.5 Million EUR -327.24%
Nanobiotix S.A. 95.74 Million EUR -107.542%
PHAXIAM Therapeutics S.A. 25.69 Million EUR -673.306%
Vivoryon Therapeutics N.V. 4.54 Million EUR -4269.936%
BioSenic S.A. 32.26 Million EUR -515.86%
ABIVAX Société Anonyme 131.05 Million EUR -51.62%
Formycon AG 387.61 Million EUR 48.737%